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Highlights 
 High levels of carbapenem resistance were detected in natural environments 
 Host species included a number of opportunistic Gram negative pathogens 
 A novel member of the DHA β-lactamase family was discovered 
 The natural environment is a reservoir of clinically relevant resistance mechanisms 
 
Abstract 
Objectives: Recent research has demonstrated that natural populations of bacteria carry large numbers of mobile 
genetic elements which may harbour antibiotic resistance determinants. The aim of this study was to investigate 
carbapenem resistance in Gram negative bacteria isolated from natural environments in Bejaia (Algeria), and 
determine the horizontal gene transfer potential of a subset of these resistance genes. 
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Methods: Resistant bacteria were isolated and host identified with MALDI-TOF/16S rRNA sequencing. 
Resistance gene carriage was investigated using double disc synergy, metallo-β-lactamase (MBL) production tests 
and PCR screening for carbapenemase resistance genes. To determine potential mobility, conjugation experiments 
were performed. To identify resistance genes, genomic libraries were constructed, functionally screened; then 
inserts were sequenced. 
Results: From soil and water samples, 62 resistant strains were classified as belonging to the Enterobacteriaceae, 
Pseudomonadaceae, Xanthomonadaceae and Aeromonadaceae families. Four highly imipenem and cefotaxime 
resistant (MICs >64 µg/ml and >8 µg/ml, respectively), clinically relevant strains were selected for further 
characterization. All four strains produced extended spectrum β-lactamases, but MBL production was not 
confirmed. Imipenem and cefotaxime resistance was transferable to E. coli strains but was not conferred by 
blaAMPc, blaIMP, blaNDM, blaKPC, blaOXA-48 or blaGES genes. Novel putative resistance mechanisms were identified, 
including a novel DHA β-lactamase which conferred clinical resistance to cefotaxime.  
Conclusions: The environment is a reservoir of carbapenem resistant bacteria. Further investigation of evolution 
and dissemination of antibiotic resistance in environmental bacteria is required, to understand and prevent the 
emergence of resistance in clinical environment. 
 
Keywords: Carbapenem, gene transfer, resistance, soil, water. 
 
1. Introduction 
The emergence of antibiotic resistance within Gram negative bacteria is a significant clinical and economic threat 
to human and animal medicine. Pseudomonas, Stenotrophomonas, Aeromonas and Enterobacteriaceae spp. are 
environmental species but are also multi-resistant, opportunistic pathogens associated with serious infections in 
humans and animals. Enterobacteriaceae are ubiquitous Gram negative microorganisms, usually colonizing the 
gut environment. They are a major cause of contamination in food and water and are one of the most important 
opportunistic pathogenic organisms in the clinical environment. They are implicated in large numbers of 
community and hospitals acquired infections and can exchange and acquire genetic information, including 
antibiotic resistance genes, via horizontal gene transfer (HGT).  
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β-lactam antibiotics are widely used in clinical therapy to treat such enteric bacterial infections. Third generation 
cephalosporins (3GCs) are β -lactams that are currently widely used; and carbapenems are one of the antibiotics 
of last resort to treat nosocomial and severe urinary tract and skin infections [1]. However, their overuse 
contributes to development of multidrug resistance among enteric bacteria [2]. Carbapenem resistance can result 
from production of β-lactamase enzymes such as extended spectrum β-lactamases (ESBLs) combined with porin 
alteration, hyper production of the AmpC enzyme coupled with loss of porin functionality; or production of β-
lactam hydrolyzing carbapenemases [3]. Using this enzymatic arsenal, multidrug resistant Gram negative bacteria 
have become a serious problem in the clinical environment [4]. 
Outside of the clinic, antibiotic molecules can be detected in aquatic and soil environments where they are 
produced by environmental microorganisms or are excreted by humans and animals. Heavy metals used in animal 
farming and aquaculture are also known to drive the evolution of antibiotic resistance within bacteria through co-
selection [5]. Numerous investigations have revealed that the environmental metagenome contains highly diverse 
antibiotic resistance genes termed the environmental “resistome” which can be horizontally transferred to new 
hosts, and that the natural environment contains reservoirs of multidrug resistant bacteria [6].  
This motivated the study of carbapenem resistant bacteria from different sites in the natural environment from 
North Africa in the Bejaia (Algeria) region. Aquatic and soil environments were screened for the presence of 
Gram negative bacteria resistant to carbapenem antibiotics. The host species of the resistant isolates were 
identified and the phenotypic resistance profiles were characterized. The HGT potential of this resistance was also 
determined for a subset of isolates.  
 
 
2. Materials and methods 
2.1 Sampling 
Soil and water samples were collected in the province of Bejaia located in North Africa. During the period of 
October to November 2013, soil samples (n=95) were collected from the rhizosphere of wild legumes (Genista 
numidica, Calycotum spinosa and Spartium junceum) growing in a coastal area, an arid region and in a heavy 
metal contaminated soil. The water samples (n=90) were obtained from natural (forest) and bore hole (80m deep) 
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water sources, animal drinking trough water and municipal wastewater. We highlight that the natural environment 
samples had not been exposed to anthropogenic antibiotics or human manipulation such as agricultural activity or 
hospital waste contamination. Samples were transported to the laboratory at 4°C for bacterial isolation.  
2.2 Isolation and bacterial characterization 
Serial dilutions in saline were prepared from each sample. One ml of bacterial suspension was inoculated in 
nutrient broth (Himedia, USA) and incubated at 37°C for 24 hours. In order to reduce the bacterial density before 
isolation, the cultures were diluted to one tenth (10-1) in saline water. Then, 100μl of each dilution was streaked 
onto MacConkey agar (Himedia, USA) supplemented with 2μg/ml of imipenem [7]. After an overnight incubation 
at 37°C, the isolates were purified and stored on agar slants and in 20% glycerol at -20°C. 
Identification of isolates was based on amplification of the 16S rRNA gene (n=22) and/or MALDI-TOF 
spectroscopy (n=40). PCR amplification was carried out using the primers 27F and 1492R and following PCR 
conditions presented in Mao et al [8]. The 16S r RNA sequences were analyzed using MEGA6 software [9], then 
compared within sequences in GenBank (NCBI).  
2.3 Antimicrobial susceptibility testing 
To examine the phenotypic resistance profiles of bacterial isolates, discs containing cefotaxime (CTX 30 µg), 
ceftazidime (CAZ 30 µg), aztreonam (ATM 30 µg), ertapenem (ETP 10 µg), meropenem (MEM 10µg) and 
imipenem (IMP 10µg) (Oxoid, UK) were used in disc diffusion assays. To achieve high turbidity, isolates were 
grown on nutrient agar (Himedia, USA) then incubated overnight at 37°C. Colonies were resuspended in 0.9% of 
saline solution to the turbidity equivalent of a 0.5 Macfarland standard. Bacterial suspensions were inoculated by 
streaking the cotton swab over the surface of Muller Hinton agar plates, then antibiotic discs were placed on the 
agar surface. After 24 hours incubation at 37°C, resistance and sensitivity was estimated by measuring the 
inhibition zones and comparing to EUCAST guidelines [10]. 
2.4 Antibiotic minimal inhibitory concentration determination 
Minimal inhibitory concentrations (MICs) were determined for imipenem and cefotaxime, following the agar 
dilution method: after 24 hours incubation at 37°C, the MICs of the strains were defined as the lowest 
concentration of antibiotic that inhibited the visible growth of bacteria [11]. Isolates possessing clinically 
significant MICs were selected for ESBLs and MBL production tests. ESBL production was screened with the 
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double disc synergy test assay (DDST) [12]. Detection of MBL production was performed following the EDTA 
test; combined disc [13] and synergy test [14]. Finally, the Carba NP test was carried out as reported in Bakour et 
al [15].       
2.5 Resistance gene transfer  
In order to determinate whether the putative resistance genes were mobile and transferable; conjugation 
experiments were performed. Conjugal transfer of the resistance gene from the isolates to a rifampicin resistant E 
coli (CV 601) recipient was performed following the broth and filter assay [16]. E. coli (CV601) was used as the 
recipient strain and Klebsiella pneumonia KX159722 (‘KP1’), Morganella morganii BHWSO8 (‘MM1’), 
Morganella morganii KX159721 (‘MM2’) and Klebsiella oxytoca KX15970 (‘KO1’), isolated in this study, were 
the donor strains. Each strain pellet was resuspended in 1 ml of LB broth, then incubated for two hours. Cells 
were harvested from the mixed suspension of 100 µl of donor and 200 µl of recipient by centrifugation for 5 
minutes at 8K rpm. The pellet was resuspended in 100 µl in Luria Bertani broth (LB) and applied on Millipore 
filter (0.22 µm) which was placed on Luria Bertani agar (LB) without antibiotic. After overnight incubation, filters 
were resuspended in 10 ml of sterile saline (0.85%) by vigorous vortexing. In order to determine the numbers of 
recipient cells, 50µl of 10-fold serial dilutions were streaked on three PCA plates supplemented with the following 
antibiotic concentrations, respectively: rifampicin (50 µg/ml), cefotaxime (2 µg/ml) and mixed rifampicin (50 
µg/ml) and cefotaxime (2µg/ml). PCA plates were then incubated for two days at 28°C. In addition, purified 
plasmid (GENE JET Plasmid miniprep Kit (Thermo Scientific)) extracted from isolates was transferred into 
competent E. coli EC-100 (Epicentre) cells by electroporation (1.4KV, 4.3 ms). Transformants were selected on 
Luria Bertani agar (LB) supplemented with ampicillin (100μg/ml), twice. Transconjugants and transformants were 
selected on Luria Bertani agar (LB) containing rifampicin (125 μg/ml) and imipenem (2μg/ml). MICs were 
determined for imipenem (0.1 - 8μg/ml), cefotaxime (0.1 – 4 μg/ml) and ampicillin (1 – 125 μg/ml). Note that for 
all experiments, E. coli CV6001 and EC-100 strains were used as negative controls and that all the analyses were 
performed in triplicate. 
2.6 Screening for known resistances genes  
Plasmid DNA was extracted from transconjugants using the GENE JET Plasmid miniprep Kit (Thermo 
Scientific), and underwent PCR amplification for resistance genes blaAMPc, blaIMP, blaNDM, blaKPC, blaOXA-48 and 
blaGES using the primers (Table S1) and cycling programmes cited in Endimiani et al [17] for AMPc and IMP 
primers and Bogaerts et al., [18] for NDM, KPC, OXA-48 and GES primers (Table S1).  
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2.7 Construction of genomic libraries 
Genomic libraries were constructed by using Electrocompetent E. coli EC-100 (Epicentre, Madison, WI) and 
fragmented DNA (≈3000-5000bp) extracted from the following resistant strains: KP1, MM1, MM2 and KO1. 
Whole genome coverage was equivalent to 103 cells. Transposon mutagenesis was carried out using CloneSmart 
Blunt Cloning Kits (Lucigen, WI, USA). Briefly, the extracted DNA was blunt ended at the 5'phosphorylated site, 
then ligated into the pSMART LcKan Vector. This was then transferred into E. coli EC-100 by electroporation 
(2.2-2.5KV) and inoculated onto LB plates. Plate 01 contained imipenem (0.5 µg/ml) plus kanamycin (0.5 µg/ml), 
plate 02 contained cefotaxime (0.5 µg/ml) plus kanamycin (0.5 µg/ml) and plate 03 contained ampicillin (25 
µg/ml) plus kanamycin (0.5 µg/ml). In order to study the clone sensitivity, imipenem (0.2 – 8 µg/ml), cefotaxime 
(0.2 - 8µg/ml), and ampicillin (1 – 125 µg/ml) MICs were carried out. 
2.8 Quality control of the genomic library  
Colonies growing on selective medium were grown in 10 mL LB medium (kanamycin 10 µg/ml). The plasmid 
was extracted according to the manufacturer’s protocol (Plasmid miniprep Kit GENE JET, Thermo Scientific, 
UK), then restricted using restriction enzymes: EcorI and Xbaz to excise the inserts of clones.  The restriction 
product was visualized by electrophoresis.    
2.9 Insert sequence analysis 
Using One Shot LA PCR Mix Ver 2.0 (TAKARA Bio INC, Japan) the insert sequences were amplified, then 
sequenced (Macrogen, Europe). Sequenced inserts were analyzed with MEGA6 and compared with other 
Enterobacteriaceae strains by using BLASTp. The ResFinder web server (www.genomicepidemiology.org) was 
used to identify acquired antimicrobial resistance genes [19].  Alignment was performed with MegAlign from the 
Lasergene software package from DNASTAR (Madison, WI). Relevant sequences deposited in GenBank are 
available under the following accession numbers: MF186235 (Klebsiella pneumoniae KX159722, ‘KP1’), 
MF186233 (Morganella morganii BHWSO8, ‘MM1’), MG701058 (Morganella morganii KX159721, ‘MM2’), 
and MF186234 (Klebsiella oxytoca KX159720, ‘KO1’). 
 
 
3. Results  
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3.1 Diversity of carbapenem resistant isolates 
In the current study of antibiotic resistant bacteria from the natural environment in Algeria, a high diversity of 
Gram negative isolates were characterized as being resistant to carbapenem antibiotics. Using MALDI-TOF mass 
spectrometry, 16S RNA PCR and sequencing, thirteen (13) out of 62 isolates were classified within the 
Enterobacteriacaea family including: Serratia marcescens (n=3), Enterobacter cloacae (n=3), Morganella 
morganii (n=2), Klebsiella pneumoniae (n=3) and Klebsiella oxytoca (n=2). Most of these isolates were from 
water, rhizosphere and saline soil. From natural water sources, two (2) isolates were identified as Aeromonas 
veronii. Eighteen (18) isolates were attributed to the genus Pseudomonas, six (6) characterized as Pseudomonas 
aeruginosa. The majority of the Pseudomonas spp. was isolated from rhizosphere soil samples. Twenty seven 
(27) isolates were identified as Stenotrophomonas maltophilia, with the majority isolated from water samples. 
Two strains isolated from soil were identified as Ochrobactrum intermedium (Table S2). For the isolates 
characterized by 16S rRNA sequencing, nucleotide sequences were deposited in GenBank (Table S2). 
Antimicrobial susceptibility and MIC tests revealed that most of the 62 isolates were resistant to imipenem 
(62.90%), ertapenem (79.03%), cefotaxime (64.51%), ceftazidime (43.54%) and aztreonam (80.64%), whilst most 
were sensitive to meropenem (30.64%) (Table S2). The highest MICs were for imipenem (>64 μg/ml) and 
cefotaxime (>8 μg/ml), equating to 8x and 4x the clinical breakpoint concentrations defined by EUCAST for 
Enterobacteriacaea [20].  
3.2 Characterization of resistance mechanisms 
Phenotypic resistance profile characterization for four multidrug resistant Enterobacteriaceae spp. (KP1, MM1, 
MM2 and KO1) was carried out due to their significance in causing clinical infections (Table 1). The first assay 
for detection of ESBLs (DD test) showed synergy results by formation of ghost inhibition zones between the 
central discs, suggesting that these isolates may possess ESBL genes. However, the MBL production tests showed 
negative results. For the EDTA test, no synergy was observed and no difference was observed between the 
inhibition zone of imipenem + EDTA and the inhibition zone of imipenem alone. For the Carba NP test, MM1, 
MM2 and KO1 isolates showed negative results; whereas for KP1, the color changed from red to yellow as early 
as 10 to 15min after incubation, indicating possible carbapenemase carriage. 
3.3 Transfer of resistance mechanisms to an E. coli recipient 
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In this study, the transfer of carbapenem resistance from donor isolates (KP1, MM1, MM2 and KO1) to the 
recipient strain E. coli (CV601) was observed. The transconjugants grew at a concentration of cefotaxime  ≥ 
4μg/ml and showed an imipenem MIC of ≥8 μg/ml, as did EC100 cells with plasmids inserted by transformation 
(Table 1). However, both transconjugants and transformants were negative for PCR detection of blaAMPC, blaIMP, 
blaNDM, blaKPC, blaOXA and blaGES genes. 
3.3 Genomic library analyses 
Genomic libraries were constructed from isolates expressing high levels of resistance to imipenem (MIC ~64 
µg/ml). Libraries contained clones with phenotypic resistance to imipenem (≥1 µg/ml and ≥ 4 µg/ml) and 
cefotaxime (≥ 4 µg/ml) – see Table 1. The analysis of DNA insert sequences was performed using BLAST. This 
revealed that KP1, MM1, MM2 and KO1 insert lengths were respectively: 3003, 2592, 1199 and 2979 base pairs.  
ORF Finder and BLASTn were used to identify potential genes conferring resistance within the genomic libraries. 
A KP1 clone bearing the insert MF186235 contained a novel blaDHA like gene. This ORF had 99% amino acid 
identity to blaDHA-16 (accession WP_063860099.1), but with 4 amino acid substitutions. The gene was flanked by 
a gene encoding aLDT IgD-like hypothetical protein (226 amino acid) on one side and by an ampR like regulatory 
protein gene as well as a helicase gene (armA) and a periplasmic binding protein on the other side. ORFs identified 
within the insert sequence MF186233 from MM1 included the transcription protein DDETnp1 (402 amino acids) 
which was flanked between two sequences encoding galactose-1-phosphate uridyl-transferase-like proteins, and 
an iron uptake protein. The resistant clone from MM2 isolate library bearing the MG701058 insert contained a 
blaTEM-116 (100% amino acid identity).  The insert sequence isolated from the KO1 library contained a protein with 
99% amino acid identity to an ATP dependent helicase (897 amino acids) and an iron uptake protein (221 amino 
acids), both from Pseudomonas aeruginosa (WP_031629204.1).   
All inserts described had their MICs redetermined in the EC100 host (Table 1). All inserts conferred clinical 
resistance to cefotaxime with MICs ≥4 µg/ml (EUCAST breakpoint 2 µg/ml). All inserts conferred reduced 
susceptibility to imipenem, relative to the EC100 control (Table 1) and conferred intermediate clinical resistance 
to imipenem with MICs of ≥4 µg/ml (EUCAST breakpoint for resistance > 2 µg/ml and < 8 µg/ml. 
 
 
4. Discussion 
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Carbapenemases and ESBLs are important resistance determinants in Gram negative pathogens, including: 
Enterobacteriaceae, Pseudomonas, Acinetobacter and Aeromonas spp [21]. Outside the clinical environment, soil 
is described as harboring the most diverse microbial populations on earth and is considered a large reservoir of 
antibiotic resistance genes [22] and multidrug resistant bacteria [7]. Previous findings from soil samples report 
resistance to β-lactams (penicillin, carbapenicillin, dicloxacillin, ampicilin) and first and second generation 
cephalosporins; these resistance profiles are mainly associated with ɣ Proteobacteria [21, 22, 23]. Resistance to 
third generation cephalosporins and carbapenems is rarely observed in natural environments, though Gudeta et 
al., have isolated carbapenem resistant bacteria from soils samples from Algeria, United Kingdom, Germany, 
Denmark, Norway, and Spain including carbapenemase producing Pedobacter, Epilithonimonas, Sphingomonas, 
Massilia, Chryseobacterium, Janthinobacterium, and Stenotrophomonas [24]. Metallo-β-lactamases have also 
been reported from non-pathogenic marine organisms (Novosphingobium pentaromativorans and Simiduia 
agarivorans) [25] and from a remote Alaskan permafrost metagenome [26]. In the current study, high levels of 
resistance to the 3GC cefotaxime and the carbapenem antibiotic imipenem were detected in a range of 
opportunistic pathogenic, Gram negative species isolated from soil and aquatic environments in North Algeria. 
These have the potential to cause infections in humans and animals, and included Serratia marcescens, 
Enterobacter cloacae, Morganella morganii, Klebsiella pneumoniae, Aeromonas veronii, Pseudomonas spp. and 
Stenotrophomonas maltophilia.  
Multidrug resistance in Stenotrophomonas maltophilia mainly involves low membrane permeability, 
chromosomally encoded multidrug resistance efflux pumps, and β-lactamase and antibiotic modifying enzymes 
[23]. Carbapenem resistance among pseudomonads, specifically P. aeruginosa, can be mediated by plasmid or 
integron-borne carbapenemases; or reduced porin expression and increased chromosomal cephalosporinase 
activity [24]. Carbapenem resistance in Enterobacteriaceae may be explained by: β-lactamase production, by 
enzymes such as ESBLs combined with porin alteration that affect antibiotic uptake, hyper production of an AmpC 
coupled with loss of porin functionality and production of β-lactamase hydrolyzing carbapenemases [3]. Here, 
high levels of resistance to imipenem and cefotaxime were observed in Klebsiella and Morganella spp. but 
common β-lactamase genes were undetectable by PCR.  
Klebsiella pneumoniae (KP1) was positive for the Carba NP test but no known carbapenemase resistance genes 
were detected with PCR (like all isolates characterized in this study). KP1 did contain a gene with high homology 
to the blaDHA gene class, namely the cephalosporinase blaDHA-16 gene but with 4 amino acid replacements, which 
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conferred reduced susceptibility to imipenem and clinical resistance to cefotaxime. One amino acid substitution 
makes a new variant, indicating the gene in this isolate is a novel gene member of blaDHA family. To our knowledge 
this is the 26th member of this family [27]. Carbapenem resistance in this isolate may be mediated by the 
expression of this blaDHA like gene, regulated by the ampR regulatory protein. The higher MICs for imipenem in 
the KP1 transconjugants and transformants relative to the clone insert host suggests the presence of multiple 
resistance mechanisms in the accessory genome of this strain. Indeed, carbapenem resistance from Klebsiella 
species is often attributed to an innate resistance such as loss of outer membrane production; or acquired resistance 
through harboring ESBLs genes such as CTX-M, SHV-2, AmpC enzymes such as ACT-1, CMY-4 or DHA-1; or 
OXA-48 [28]. Gupta et al and Erdemli et al in their recent investigations also report L-D transpeptidase activity 
as the major contributor of β-lactam resistance in Mycobacterium tuberculosis [29], which was flanking the novel 
DHA-16 like gene. This isolate was isolated from water in a forest site unimpacted by human activities, which 
suggests a possible environmental origin of the clinically important resistance blaDHA genes. The environmental 
resistome has been shown to be a source for problematic clinical resistance previously; for example, the ESBL 
CTX-M is believed to have originated from the chromosome of an environmental Kluyvera spp. [30]. 
Morganella morganii (MM1) clone insert contained two copies of galactose-1-phosphate uridyltransferase (galT) 
-like proteins. GalT is a key enzyme in the LeLoir pathway which converts galactose-1-phosphate into UDP-
galactose. UDP-galactose is required for exopolysaccharide synthesis and so may confer antibiotic resistance by 
reduced compound uptake into the bacterial cell. In addition, UDP-galactose-4-epimerases encoded by galE genes 
perform the final step in the LeLoir pathway, by converting UDP-galactose into UDP-glucose [31]. GalE genes 
have been shown previously to have a role in resistance to a range of antibiotics and some biocides [32, 33], again 
presumably by reduced drug uptake due to production of exopolysaccharide or lipopolysaccharide [34].  There is 
therefore increasing evidence genes involved in the LeLoir pathway can have a secondary role of conferring 
reduced susceptibility to antibiotics and other antimicrobials, and in this case, two copies of this gene resulted in 
clinical resistance to cefotaxime and intermediate resistance to imipenem. Previous work has shown that other 
mechanisms including HU DNA-binding proteins, the GroEL/GrOES chaperonin complex and GrpE proteins 
may contribute to carbapenem resistance [35]. 
The Morganella morganii (MM2) isolate was positive for the β-lactamase assay and was shown to harbor a blaTEM-
116 gene. A previous study which characterized the phenotype of this resistance gene in clinically-isolated E. coli, 
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found blaTEM-116 conferred only reduced susceptibility to imipenem [36]; unlike this study which showed it can 
confer intermediate clinical resistance. This could be due to the genetic context of the gene.  
The predicted proteins responsible for resistance in the Klebsiella oxytoca (KO1) clone had highest hits for ATP-
dependent helicase and iron uptake proteins. Mutations in key bacterial enzymes involved in DNA processing 
such as gyrase and topoisomerase IV can result in fluoroquinolone resistance [37]. However, the iron uptake 
protein is a transporter protein and may confer resistance through efflux of β-lactam antibiotics.  
In Gram negative bacteria, dissemination of antimicrobial resistance is often attributed to HGT of resistance genes 
encoded on plasmids. This phenomenon is considered the principal reason for the acquisition of resistance in 
bacterial pathogens causing community or hospital acquired infections [38]. HGT may occur between bacteria of 
different species and genera, occupying natural environments or colonizing different areas of a host species [39]. 
A subset of highly resistant Enterobacteriaceae isolates in the present study, were shown to harbor transferable 
mobile resistance mechanisms conferring clinical resistance to cefotaxime and, in some cases, resistance or 
intermediate resistance to imipenem depending on host background. Though the MICs to imipenem reduced when 
strains were subcloned and expressed in E. coli, this is common and can be attributed to a range of factors including 
lower gene expression compared to the original host and improper protein folding, amongst other reasons. As 
carbapenem resistance was transferable but not detectable by PCR for well-known resistance genes, this suggests 
the isolates identified in this study possess novel mechanisms, including those characterized in this study, that 
have the potential to be mobilized into bacteria in the human microbiome. Woodford et al state that “active 
surveillance and monitoring for carbapenem-resistant bacteria in the food chain and other non-human sources is 
urgently needed, with an enhanced and rigorous follow-up of all positive results” [40].  These results, combined 
with detection of a novel member of the AmpC DHA β-lactamase family and blaTEM-116, suggest environmental 
monitoring could be valuable for identifying resistance genes which could become clinically significant in the 
future.   
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Table 1. Cefotaxime (TAX) and Imipenem (IMP) MICs for the original host species, lab strains CV601 
and EC100 bearing conjugated and transformed plasmid DNA respectively, and resistant clones from 
the EC100 genomic libraries. Colour indicates growth, no colour indicates no growth. 
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